Rosuvastatin adherence app study in China - eHELP China

Study identifier:D3560C00088

ClinicalTrials.gov identifier:NCT02433288

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomized, two-arm, open, 24-week study to evaluate the effect of a smart phone-based patient support tool on duration of treatment in patients prescribed rosuvastatin in China

Medical condition

Dyslipidemia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

885

Study type

Interventional

Age

18 Years - 80 Years

Date

Study Start Date: 20 Jul 2015
Primary Completion Date: 28 Oct 2016
Study Completion Date: 28 Oct 2016

Study design

Allocation: Randomized
Endpoint Classification: Efficacy
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care

Verification:

Verified 01 Aug 2018 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria